Aprea Therapeutics
APRE
APRE
27 hedge funds and large institutions have $1.11M invested in Aprea Therapeutics in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 13 reducing their positions, and 8 closing their positions.
Holders
27
Holders Change
-7
Holders Change %
-20.59%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
13
Closed
8
Calls
$385K
Puts
$8K
Net Calls
+$377K
Net Calls Change
-$90K
Top Buyers
1 |
1
Millennium Management
New York
|
$79K |
2 |
2
BNP Paribas Financial Markets
Paris,
France
|
$40.2K |
Top Sellers
1 |
1
Jane Street
New York
|
$0 |
2 |
2
D.E. Shaw & Co
New York
|
$0 |
3 |
CM
3
Crestline Management
Fort Worth,
Texas
|
$0 |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$201K |
5 |
5
Two Sigma Investments
New York
|
$11K |